Eargo Inc
NASDAQ:EAR
Eargo Inc
Revenue
Eargo Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Eargo Inc
NASDAQ:EAR
|
Revenue
$37.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
See Also
What is Eargo Inc's Revenue?
Revenue
37.3m
USD
Based on the financial report for Dec 31, 2022, Eargo Inc's Revenue amounts to 37.3m USD.
What is Eargo Inc's Revenue growth rate?
Revenue CAGR 5Y
41%
Over the last year, the Revenue growth was -44%. The average annual Revenue growth rates for Eargo Inc have been 4% over the past three years , 41% over the past five years .